Unlocking the Potential of Induced Pluripotent Stem Cells in Revolutionizing Cancer Therapy

This article highlights the potential of iPSC- based NK cells and dendritic cells for immunotherapy and delves into the role of iPSC-based mesenchymal cells in targeted therapy. The potential of iPSC-derived organoids as a vital tool for disease modeling and drug discovery has been showcased, and the importance of iPSC-based cancer vaccines is also emphasized. The ongoing clinical trials of iPSC-based cancer treatment have also been highlighted. Though much work remains to be done to implicate these iPSC-based therapeutic options from research labs to clinics and hospitals, ongoing studies and clinical/translational follow-ups raise hope for novel cancer therapies employing iPSC technology.PMID:38629370 | DOI:10.2174/011574888X294791240408055222
Source: Current Stem Cell Research and Therapy - Category: Stem Cells Authors: Source Type: research